All stories tagged :

People

South Africa Health and Beauty Spa Market Report 2024 – Spend...

admin
People

Rainbow Arrow: A Journey Through Michael Bokrosh’s Mesmerizing Optical Glass Universe

admin
People

Botanical Supplement Market to Reach $19.2 Billion, at a CAGR of...

admin
People

AMAZON PRIME DAY 2024 EARLY RESULTS ARE IN, NUMERATOR REPORTS

admin
People

Loupe Introduces Instant Collector-To-Collector Selling and Buying

admin
People

Guardforce AI Expands Contracts with Two Major Retail Customers

admin
People

Beat the Summer Heat with Gorgeous Hair: Top Tips and Products...

admin
People

ODDITY Appoints Yehoshua (Shuki) Nir to its Board of Directors

admin
People

New Book – FULFILLED: UNLOCKING PASSION, PURPOSE, AND JOY IN YOUR...

admin
People

Fresh Colors, Textures and Patterns on Tap for Capel Rugs’ Las...

admin
People

Energy based Aesthetic Devices (EAD) Research Report 2024 – Global Market...

admin

Featured

Pr Newswire

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business...

admin
Pr Newswire

Nusano to Present at William Blair Virtual Radiopharmaceuticals Event

admin
Pr Newswire

VTech Announces 2024/2025 Interim Results

admin
Pr Newswire

Xinhua Silk Road: Side event of CIIE held by Bailian Group...

admin
admin

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business...

Phase 3 data from KOASTAL-1 study of navacaprant in MDD expected around the end of 2024; KOASTAL-2 and KOASTAL-3 topline data expected in the first half of 2025 Ongoing clinical studies evaluating navacaprant in bipolar depression and NMRA-511 in Alzheimer’s disease agitation...